Loading...
01/11 16:19
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presented mixed signals. Positive aspects include revenue and EBITDA exceeding guidance, sequential growth, and a share buyback program. However, the EPS miss, regulatory risks, and competitive pressures introduce uncertainties. The Q&A highlighted ongoing challenges in the cannabis industry and lack of clarity on regulatory strategies. These factors balance out, leading to a neutral sentiment.
Q4 2024 Revenue $47.7 million, a year-over-year increase of X% (exact percentage not provided). This growth is attributed to sequential growth and profitability.
Full Year 2024 Revenue $184.5 million, a year-over-year increase of Y% (exact percentage not provided). This reflects the overall performance and growth throughout the year.
Q4 2024 Adjusted EBITDA $11.9 million, a year-over-year increase of Z% (exact percentage not provided). This increase is part of the sequential growth and profitability.
Full Year 2024 Adjusted EBITDA $42.9 million, a year-over-year increase of A% (exact percentage not provided). This is indicative of the company's overall financial health and operational efficiency.
Q4 2024 EPS $0.02, which missed expectations of $0.04. The reasons for the miss were not specified.
Revenue: For the fourth quarter, we delivered $47.7 million in revenue, bringing our full year revenue to $184.5 million.
Adjusted EBITDA: We achieved $11.9 million in adjusted EBITDA for the fourth quarter, totaling $42.9 million for the full year.
New Chief Technology Officer: Welcomed new Chief Technology Officer, Sarah Griffiths, who has a background in data, marketplaces, and highly regulated industries.
Earnings Expectations: WM Technology, Inc. missed earnings expectations with a reported EPS of $0.02, while expectations were $0.04.
Forward-Looking Statements: The company cautioned that forward-looking statements are subject to various risks and uncertainties, which could lead to actual results differing materially from expectations.
Regulatory Risks: The company operates in a highly regulated industry, which may pose challenges and risks to its business operations.
Market Competition: There are competitive pressures in the marketplace that could impact WM Technology's performance and market share.
Economic Factors: Economic conditions may affect the company's business activities and financial performance.
Supply Chain Challenges: Potential supply chain challenges could impact the company's ability to deliver products and services effectively.
New Chief Technology Officer: Welcomed Sarah Griffiths as the new Chief Technology Officer, who has a strong background in data, marketplaces, and highly regulated industries.
Sequential Growth: Achieved another quarter of sequential growth and profitability.
Q4 Revenue: Reported revenue of $47.7 million for Q4 2024.
Full Year Revenue: Full year revenue reached $184.5 million.
Adjusted EBITDA: Achieved adjusted EBITDA of $11.9 million for Q4 and $42.9 million for the full year.
Earnings Expectations: Reported EPS of $0.02, missing expectations of $0.04.
Share Buyback Program: The company announced a share buyback program of $10 million, aimed at enhancing shareholder value.
Dividend Program: No dividend program was discussed during the call.
The earnings call highlights revenue decline, price compression, and regulatory challenges, which are significant concerns. While the company maintains profitability and cash reserves, the negative trends in core markets and client churn overshadow the positives. The lack of clear guidance and the focus on long-term prospects at the expense of near-term revenue add to the uncertainty, suggesting a negative market reaction.
The earnings call summary presents mixed signals. While there is modest revenue growth and positive cash generation, regulatory challenges and declining client spending pose risks. The Q2 guidance shows stability but lacks significant upside. Product development and client base growth are positive, but operational challenges and market pressures could offset gains. Without a strong catalyst or significant market cap details, the stock price is likely to remain stable in the near term.
The earnings call presented mixed signals. Positive aspects include revenue and EBITDA exceeding guidance, sequential growth, and a share buyback program. However, the EPS miss, regulatory risks, and competitive pressures introduce uncertainties. The Q&A highlighted ongoing challenges in the cannabis industry and lack of clarity on regulatory strategies. These factors balance out, leading to a neutral sentiment.
The earnings call highlights mixed signals: a slight revenue decline for the full year, but improved Q4 performance and profitability. Regulatory and competitive pressures pose risks, but management's optimism and new product launches offer potential upside. The Q&A reveals some uncertainty, particularly around supply chain issues and product timelines. Overall, the sentiment remains neutral, with no major catalysts for a significant stock move in either direction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
